135 related articles for article (PubMed ID: 14751140)
1. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix.
Utsugi K; Shimizu Y; Akiyama F; Umezawa S; Hasumi K
Gynecol Oncol; 2004 Jan; 92(1):64-70. PubMed ID: 14751140
[TBL] [Abstract][Full Text] [Related]
2. Villoglandular papillary adenocarcinoma of the uterine cervix with bulky lymph node metastases.
Utsugi K; Shimizu Y; Akiyama F; Hasumi K
Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):186-8. PubMed ID: 12381485
[TBL] [Abstract][Full Text] [Related]
3. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
Datta CK
W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
[TBL] [Abstract][Full Text] [Related]
4. Villoglandular papillary adenocarcinoma of the cervix: a series of 28 cases including two with lymph node metastasis.
Lataifeh IM; Al-Hussaini M; Uzan C; Jaradat I; Duvillard P; Morice P
Int J Gynecol Cancer; 2013 Jun; 23(5):900-5. PubMed ID: 23552807
[TBL] [Abstract][Full Text] [Related]
5. Well-Differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis.
Khunamornpong S; Maleemonkol S; Siriaunkgul S; Pantusart A
J Med Assoc Thai; 2001 Jun; 84(6):882-8. PubMed ID: 11556470
[TBL] [Abstract][Full Text] [Related]
6. Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report.
Nagai N; Hirata E; Kusuda T; Mukai K; Arihiro K; Ohama K
Int J Gynecol Cancer; 2005; 15(6):1187-90. PubMed ID: 16343210
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
8. Villoglandular papillary adenocarcinoma of the uterine cervix: A report of 4 cases and a review of the literature.
Zhou QY; Chen HY; Yang SM; Li YH; Wu XQ
Oncol Lett; 2016 Jan; 11(1):837-841. PubMed ID: 26870293
[TBL] [Abstract][Full Text] [Related]
9. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.
Zhou C; Gilks CB; Hayes M; Clement PB
Am J Surg Pathol; 1998 Jan; 22(1):113-20. PubMed ID: 9422324
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
11. Villoglandular papillary adenocarcinoma of the uterine cervix with immunohistochemical characteristics.
Polat A; Düsmez D; Pata O; Aydin O; Egilmez R
J Exp Clin Cancer Res; 2002 Sep; 21(3):425-7. PubMed ID: 12385589
[TBL] [Abstract][Full Text] [Related]
12. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases.
Young RH; Scully RE
Cancer; 1989 May; 63(9):1773-9. PubMed ID: 2702584
[TBL] [Abstract][Full Text] [Related]
13. Conservative management for villoglandular papillary adenocarcinoma of the cervix diagnosed during pregnancy followed by a successful term delivery: a case report and a review of the literature.
Lavie O; Segev Y; Peer G; Gutterman E; Sagie S; Auslnader R
Eur J Surg Oncol; 2008 May; 34(5):606-8. PubMed ID: 17643913
[No Abstract] [Full Text] [Related]
14. Villoglandular papillary adenocarcinoma of the uterine cervix.
Collinet P; Prolongeau JF; Vaneecloo S
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):101-3. PubMed ID: 10471150
[TBL] [Abstract][Full Text] [Related]
15. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
Reed W; Abeler VM; Tropé CG
Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
[TBL] [Abstract][Full Text] [Related]
16. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of microinvasive cervical cancer: analysis of pathologic features with implications on radicality.
Yoneda JY; Braganca JF; Sarian LO; Borba PP; Conceição JC; Zeferino LC
Int J Gynecol Cancer; 2015 May; 25(4):694-8. PubMed ID: 25742569
[TBL] [Abstract][Full Text] [Related]
18. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
Tian QF; Wang XY; Lü WG; Ye F; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
